<DOC>
	<DOCNO>NCT02717117</DOCNO>
	<brief_summary>Crohn 's disease ( CD ) become common . One main feature disease weight loss malnutrition symptom tummy ache bloat . These problem strong negative effect patient ' quality life cause problem well understood . Enteroendocrine cell nutrient sensor bowel secrete special chemical ( call hormone ) control appetite movement gut . The investigator think control mechanism go wrong Crohn 's patient set research . Looking inside work gut always difficult time unpleasant patient , however recent development magnetic resonance imaging ( MRI ) allow investigator study working gut great detail without discomfort patient . Before study Crohn 's patient necessary run set pilot experiment healthy volunteer use test meal subsequent MRI image look motion gut . This validation stage methodology essential embark detailed study patient .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Motility Crohn 's 1</brief_title>
	<detailed_description>Background : Poor nutrition Crohn 's disease ( CD ) common poorly understood . Apart disease burden repeat surgery , reduction appetite might aetiological factor . Enteroendocrine cell ( EC ) intraluminal nutrient sensor . They play pivotal role orchestrate physiological function gastrointestinal tract . Sensing nutrient content lumen , secrete multiple peptide amine control gut secretory motor function . CD patient small bowel inflammation show increase expression EC peptide exaggerate postprandial response anorectic EC hormone . This associate symptom nausea anorexia , EC-peptide expression decrease normality remission . There longstanding interest effect CD gastric empty gastrointestinal motility . Recent technological advance allow u use magnetic resonance imaging ( MRI ) measure disease activity , intestinal motility whole gut transit . Reduced intestinal motility recently show CD patient active terminal ileal disease . A significant negative correlation observe terminal ileal motility histological , biochemical radiological measure disease activity . Intestinal hypomotility may observe proximal unaffected segment small bowel well . An increase EC activity could potentially lead altered appetite symptom nausea delay gastric empty importantly delay small bowel transit . This mechanistic link describe present finding correlate patient symptom . This work potentially open new therapeutic pathway CD therapy . Optimisation study healthy volunteer ( HV ) urgently need . Aims &amp; Hypothesis : In intestinal inflammation due CD , observe up-regulation fasting postprandial EC peptide may correlate delayed whole gut transit specifically small bowel transit gastric emptying . This optimization study HV aim validate test meal optimize themethodology assess gastric emptying , small bowel transit whole gut transit . Experimental protocol method : 15 healthy volunteer recruit . Standard MRI exclusion criterion apply . Volunteers history inflammatory bowel disease , history smoking , history bowel resection gastric surgery , history pancreatic insufficiency , thyroid disease , diabetes , protein-pump inhibitor usage medication affect gastric empty small bowel transit . This study open-label design . Subjects ask swallow five MRI marker capsule ( 20 x 7 mm ) 09:00 , 24 h undergoing MRI scan . The subject ask fast 2000 h. They ask fill questionnaire ensure adherence study day restriction . On day scan , allow small glass water wake . They undergo baseline fasting scan 0900 hour ( define = -45 min time point ) , together fast baseline blood sample . At 0925 hour , ask eat test meal within maximum time 20 min 0945 hour subject undergo first immediate postprandial scan ( define = 0 min ) . This follow data collection ( MRI , questionnaire data blood sample ) time point every 15 min first 60 min every 30 min 270 min . At time point , position subject , setup data collection take ~15min . After first 60 min , completion data collection time-point , volunteer keep sit upright quiet lounge next scanner . At time point , volunteer fill 100mm Visual Analogue Scale ( VAS ) symptom questionnaire score feeling fullness , bloating , distension , abdominal pain/discomfort nausea . The VAS anchor 'not ' 'extremely ' . Participants give meal end study . MRI scan carry supine either 1.5T 3.0 T Philips Achieva MRI scanner ( Philips Healthcare , Best , The Netherlands ) depend availability . Fasting post-prandial plasma test : On morning test , 10 ml fast blood sample drawn aprotonin/EDTA tube ( BD-361017 , BD Diagnostics , Oxford ) . Samples measure every 45 min 270 min . Samples centrifuge 4000 rpm 5 min store ice . Measurement plasma peptide : All EC peptide ( GLP-1 , PYY ) analyse ELISA technique ( Millipore , UK ) . Serum CCK measure RIA ( Euro Diagnostic Products , Sweden ) . Total EC plasma peptide response present per individual time point compositely area curve ( AUC ) .</detailed_description>
	<criteria>Healthy Body Mass Index ( BMI ) : 1830 Kg/m2 Patients history inflammatory bowel disease . Smokers . A history bowel resection gastric surgery . History pancreatic insufficiency , thyroid disease or/and diabetes . Proteinpump inhibitor usage medication affect gastric empty small bowel transit . Any potential participant score highly depression scale questionnaire . Standard MRI exclusion criterion ( e.g . pacemaker ) . Malignant disease Stricturing penetrate disease Smoking history History bowel resection gastric surgery Significant cardiovascular respiratory disease Current Infection Neurological cognitive impairment Significant physical disability Significant hepatic disease renal failure Subjects currently ( last three month ) participate another research project pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Motility</keyword>
	<keyword>MRI</keyword>
	<keyword>Gut peptide</keyword>
	<keyword>Feeding</keyword>
</DOC>